Glutamatergic And GABAergic Disturbances In Individuals At Ultra-high Risk Of Psychosis: Implications For Clinical And Functional Outcome

被引:0
|
作者
Wenneberg, Christina [1 ,2 ,4 ]
Glenthoj, Birte Yding [2 ,3 ]
Broberg, Brian Villumsen [2 ,3 ]
Glenthoj, Louise Birkedal [1 ,2 ]
Kristensen, Tina Dam [1 ,2 ]
Krakauer, Kristine [1 ,2 ,4 ]
Rostrup, Egill [4 ]
Nordentoft, Merete [1 ,2 ]
机构
[1] Mental Hlth Ctr Copenhagen, Copenhagen, Denmark
[2] Ctr Clin Intervent & Neuropsychiat Schizophrenia, Copenhagen, Denmark
[3] Ctr Neuropsychiat Schizophrenia Res, Copenhagen, Denmark
[4] Funct Imaging Unit, Copenhagen, Denmark
关键词
D O I
暂无
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
C136
引用
收藏
页码:236 / 236
页数:1
相关论文
共 50 条
  • [1] GLUTAMATERGIC AND GABAERGIC DISTURBANCES IN INDIVIDUALS AT ULTRA-HIGH RISK OF PSYCHOSIS: IMPLICATIONS FOR CLINICAL AND FUNCTIONAL OUTCOME
    Wenneberg, Christina
    Glenthoj, Birte Y.
    Broberg, Brian V.
    Glenthoj, Louise B.
    Kristensen, Tina D.
    Krakauer, Kristine
    Rostrup, Egill
    Nordentoft, Merete
    [J]. SCHIZOPHRENIA BULLETIN, 2017, 43 : S142 - S142
  • [2] STRIATAL GABAERGIC AND GLUTAMATERGIC DYSREGULATIONS AS POTENTIAL PREDICTORS OF CONVERSION TO PSYCHOSIS IN INDIVIDUALS AT ULTRA-HIGH RISK
    de la Fuente-Sandoval, Camilo
    Leon-Ortiz, Pablo
    Mao, Xiangling
    Reyes-Madrigal, Francisco
    Rodriguez-Mayoral, Oscar
    Alvarado-Alanis, Patricia
    Solis-Vivanco, Rodolfo
    Favila, Rafael
    Graff-Guerrero, Ariel
    Shungu, Dikoma C.
    [J]. SCHIZOPHRENIA RESEARCH, 2014, 153 : S33 - S34
  • [3] Striatal GABAergic and Glutamatergic Dysregulations as Potential Predictors of Conversion to Psychosis in Individuals at Ultra-high Risk
    de la Fuente-Sandoval, Camilo
    [J]. NEUROPSYCHOPHARMACOLOGY, 2014, 39 : S44 - S45
  • [4] Neuroanatomical Predictors of Functional Outcome in Individuals at Ultra-High Risk for Psychosis
    Reniers, Renate L. E. P.
    Lin, Ashleigh
    Yung, Alison R.
    Koutsouleris, Nikolaos
    Nelson, Barnaby
    Cropley, Vanessa L.
    Velakoulis, Dennis
    McGorry, Patrick D.
    Pantelis, Christos
    Wood, Stephen J.
    [J]. SCHIZOPHRENIA BULLETIN, 2017, 43 (02) : 449 - 458
  • [5] Glutamatergic disturbances in subjects at ultra-high risk of psychosis and the effect of cognitive remediation therapy
    Wenneberg, Christina
    Nordentoft, Merete
    Glenthoj, Birte Yding
    Rostrup, Egill
    Glenthoj, Louise Birkedal
    Krakauer, Kristine
    Nordholm, Dorte
    Randers, Lasse
    [J]. EARLY INTERVENTION IN PSYCHIATRY, 2014, 8 : 168 - 168
  • [6] Bullying in individuals at ultra-high risk for psychosis
    Fekih-Romdhane, Feten
    Cheour, Majda
    [J]. ANNALES MEDICO-PSYCHOLOGIQUES, 2023, 181 (04): : 325 - 329
  • [7] Child Maltreatment and Clinical Outcome in Individuals at Ultra-High Risk for Psychosis in the EU-GEI High Risk Study
    Kraan, Tamar C.
    Velthorst, Eva
    Themmen, Manouk
    Valmaggia, Lucia
    Kempton, Matthew J.
    McGuire, Phillip
    van Os, Jim
    Rutten, Bart P. F.
    Smit, Filip
    de Haan, Lieuwe
    van der Gaag, Mark
    [J]. SCHIZOPHRENIA BULLETIN, 2018, 44 (03) : 584 - 592
  • [8] Prediction of Functional Outcome in Individuals at Clinical High Risk for Psychosis
    Carrion, Ricardo E.
    McLaughlin, Danielle
    Goldberg, Terry E.
    Auther, Andrea M.
    Olsen, Ruth H.
    Olvet, Doreen M.
    Correll, Christoph U.
    Cornblatt, Barbara A.
    [J]. JAMA PSYCHIATRY, 2013, 70 (11) : 1133 - 1142
  • [9] Clinical and brain structural predictors of 'Transition to Psychosis' or 'Risk Remission' in individuals at ultra-high risk for psychosis
    Krakauer, Kristine
    Glenthoj, Birte Y.
    Rostrup, Egill
    Ebdrup, Bjorn H.
    Randers, Lasse
    Nordholm, Dorte
    Glenthoj, Louise B.
    Wenneberg, Christina
    Nordentoft, Merete
    [J]. EARLY INTERVENTION IN PSYCHIATRY, 2014, 8 : 147 - 147
  • [10] Attribution bias in individuals at ultra-high risk for psychosis
    Park, Hye Yoon
    Bang, Minji
    Lee, Su Young
    Song, Yun Young
    Lee, Eun
    An, Suk Kyoon
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 : 241 - 242